Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: preliminary results (Q44390093)

From Wikidata

Jump to navigation Jump to search

scientific article published in February 2003

edit

Language	Label	Description	Also known as
English	Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: preliminary results	scientific article published in February 2003

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12675321

retrieved

2 December 2017

title

Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: preliminary results (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12675321

retrieved

2 December 2017

main subject

oligodendroglioma

1 reference

based on heuristic

inferred from title

temozolomide

0 references

adult oligodendroglioma

1 reference

based on heuristic

inferred from title

author name string

Ali Chahlavi

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12675321

retrieved

2 December 2017

Andrew Kanner

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12675321

retrieved

2 December 2017

David Peereboom

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12675321

retrieved

2 December 2017

Susan M Staugaitis

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12675321

retrieved

2 December 2017

Paul Elson

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12675321

retrieved

2 December 2017

Gene Barnett

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12675321

retrieved

2 December 2017

publication date

1 February 2003

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12675321

retrieved

2 December 2017

published in

Journal of Neuro-Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12675321

retrieved

2 December 2017

volume

61

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12675321

retrieved

2 December 2017

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12675321

retrieved

2 December 2017

page(s)

267-273

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12675321

retrieved

2 December 2017

cites work

Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of clinical features and telomerase activity in human gliomas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Temozolomide chemotherapy in recurrent oligodendroglioma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proliferating cell nuclear antigen and Ki-67 immunohistochemistry of oligodendrogliomas with special reference to prognosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oligodendrogliomas: the Mayo Clinic experience

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oligodendrogliomas. Part II: A new grading system based on morphological and imaging criteria

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oligodendrogliomas. Part I: Patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oligodendrogliomas. I. A clinical study of cerebral oligodendrogliomas.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-grade glioma. To treat or not to treat?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oligodendroglioma: the Rotterdam-Dijkzigt experience

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cerebral oligodendroglioma: prognostic factors and life history.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Charing Cross Hospital experience with temozolomide in patients with gliomas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A clinicopathological study of 323 patients with oligodendrogliomas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenic events in oligodendroglial tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does chemotherapy benefit the patient with a central nervous system glioma?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic Factors in Oligodendroglioma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CDKN2/p16 predicts survival in oligodendrogliomas: comparison with astrocytomas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful chemotherapy for recurrent malignant oligodendroglioma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Temozolomide: a new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of the proliferation-related antigen Ki-67 in oligodendrogliomas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of radiotherapy versus radiotherapy plus CCNU for incompletely resected low-grade gliomas: a Southwest Oncology Group study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of oligodendrogliomas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aggressive oligodendroglioma: a chemosensitive tumor

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of temozolomide (NSC 362856) in patients with advanced cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinicopathologic correlations in the oligodendroglioma.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Procarbazine, lomustine, and vincristine (PCV) chemotherapy for grade III and grade IV oligoastrocytomas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy for the treatment of oligodendroglial tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term outcome of low-grade oligodendroglioma and mixed glioma.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-grade glial tumors in basal ganglia and thalamus: natural history and biological reappraisal

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12675321

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1023/A:1022580610598

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12675321

retrieved

2 December 2017

Dimensions Publication ID

1007951825

0 references

PubMed publication ID

12675321

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12675321

retrieved

2 December 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44390093&oldid=2206613431"